February 2026 – Dubai, UAELanding Med successfully participated in WHX Labs Dubai 2026, one of the region’s premier laboratory and diagnostics events, where the company presented its latest advancem...
January 19, 2026 Landing Med has been selected for the World Economic Forum’s MINDS (Meaningful, Inclusive, and Novel Data Solutions) 2nd cohort, becoming the only pathology-focused company recognize...
Singapore — August 1, 2025 — Landing Med is pleased to announce the successful deployment of the LD Patho 320A portable digital pathology slide scanner at the Institute of Molecular and Cell Biology...
Landing Med is proud to announce that our Founder and Chairwoman, Dr. Xiaorong Sun, has been named to The Pathologist Power List 2025, featured in this year’s Leading Voices edition.
Recently, at the inaugural Africa Digital Pathology Congress, Wuhan Landing Intelligence Medical Co., Ltd. (hereinafter referred to as Landing Med) became a focal point with its independently develope...
Manila, Philippines – July 8, 2025 — Landing Med, a global leader in AI-powered cervical cancer screening, has been recognized with a Top 3 Innovation Award at the inaugural Asian Development Bank (...
July 3, 2025 – Wuhan, China – Dr. Xiaorong Sun, Founder and Chairwoman of Landing Med, has been named to the 2025 Fortune China Most Powerful Women “Future List” (MPW), recognizing her pioneering ...
June 28, 2025 – Wuhan, China – Landing Med, a global leader in AI-powered cervical cytology screening, has been named one of the Top 50 AI Technology Enterprises in China by Forbes China. The announ...
On May 11, 2025, the 2025 Forbes China Top 50 Artificial Intelligence Technology Companies list was officially released. Landing Med earned a coveted position on the list, standing out as the only com...